Research is the starting point. Inocule investigates emerging science, validates opportunities and selectively builds toward products, intellectual property and businesses.
Identify scientific and technological developments with transformative potential.
Research, technical investigation, market analysis and specialist consultation.
Assess scientific feasibility, practical application, risk and commercial potential.
Build teams, partnerships, intellectual property, prototypes or therapeutic programs.
Create products, companies, partnerships or licensing opportunities where appropriate.
Inocule expects much of its progress to come through collaboration with universities, laboratories, technology companies, clinicians, manufacturers, investors and specialist scientific teams.
Work with external scientific and technical specialists.
Access technologies and intellectual property that accelerate development.
Support promising technologies, teams and businesses as opportunities mature.
Gene editing, genomic diagnostics and cellular modification.
Cells, tissues, biomaterials and biological repair.
Neural interfaces, computation and sensory restoration.
Manufacturing biological structures and patient-specific tissues.
Engineering systems that restore or augment physical function.
Materials that enable new interactions between biology and machines.